Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day
Natco Pharma said it will manufacture Olaparib tablets, while its partner Alembic Pharmaceuticals wil distribute the product in the U.S.
· 7/20/2026, 3:07:18 PM· 2 min read
Natco Pharma said it will manufacture Olaparib tablets, while its partner Alembic Pharmaceuticals wil distribute the product in the U.S.
Read original story →Related stories
business
Why Andy Burnham will find it so tricky to unite Britain
business
'I made £100,000 of TikTok sales in one day': The business of live shopping
business
Beer industry saw challenging times during FY26 due to West Asia crisis, says UBL MD
business